How rare is Waardenburg syndrome?

Waardenburg syndrome is classified as uncommon. The estimated prevalence is approximately 1-9 in 100,000. Because rare disease data can be limited, actual numbers may differ from published estimates.

How is Waardenburg syndrome diagnosed?

Information about diagnosis is currently limited for this condition.

Are there treatments for Waardenburg syndrome?

Information about treatment is currently limited for this condition.

What are the potential complications of Waardenburg syndrome?

Waardenburg syndrome can lead to varying degrees of hearing loss, which may affect communication and social interactions. Some individuals may also experience minor defects in structures that develop from neural crest cells. Because each case is unique, the specific complications can differ from person to person.

How does Waardenburg syndrome affect daily life?

Living with Waardenburg syndrome can mean managing hearing loss and dealing with changes in pigmentation of the eyes, hair, and skin. People may need to use hearing aids or other assistive devices to help with communication. It's important for families to support individuals in adapting to these changes and finding ways to express their unique identities.

What is the prognosis for someone with Waardenburg syndrome?

The prognosis for Waardenburg syndrome can vary widely because it depends on the severity of symptoms and the specific type of the syndrome. While some individuals may have mild symptoms and lead normal lives, others may face more significant challenges, especially with hearing loss. Unfortunately, detailed information about long-term outcomes is currently limited.

Can Waardenburg syndrome affect family planning?

Yes, Waardenburg syndrome can have implications for family planning. Since it is a genetic condition, there may be a chance of passing the syndrome to children, depending on the genetic type. Families may want to consult with a genetic counselor to understand the risks and make informed decisions about having children.

Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

Waardenburg syndrome - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

Waardenburg syndrome

MONDO:0018094

Also known as:Waardenburg Shah syndromeWaardenburg's syndromevan der Hoeve Halbertsona Waardenburg syndrome

Find Clinical TrialsTrials

Overview

A disorder characterized by varying degrees of deafness and minor defects in structures arising from neural crest, including pigmentation anomalies of eyes, hair, and skin. WS is classified into four clinical and genetic phenotypes.

Clinical Trials1 registered

Clinical Presentation

Built from Human Phenotype Ontology (HPO) phenotype annotations and GeneReviews clinical descriptions. Features represent findings documented across known cases — not an exhaustive list of possible symptoms.

No HPO annotations are available for this condition.

GeneReviews

Clinical Guidance

The phenotype of Waardenburg syndrome type I (WS1) is variable even within a family. summarized the penetrance (percentage) of clinical features of WS1 in 60 individuals with WS1 and 210 affected individuals reported elsewhere in the literature. reviewed the clinical features of the Waardenburg syndromes, and discussed their screening program for Waardenburg syndrome in Colombia, detailing the percentage of each clinical manifestation; percentages similar to those found in the study were documented. However, ascertainment bias was evident, as all 95 affected individuals had hearing loss and were among the institutionalized deaf population in Colombia.

Diagnosis

Drawn from GeneReviews diagnostic guidelines, newborn screening panel status (RUSP), and ClinGen gene-disease validity classifications. Reflects current clinical evidence and consensus where available.

GeneReviews

Diagnostic Criteria

Suggestive Findings

Waardenburg syndrome type I (WS1) should be suspected in individuals with several of the following major and minor criteria.

Major criteria

Congenital sensorineural hearing loss
White forelock, hair hypopigmentation
Pigmentation abnormality of the iris:

Treatment

Compiled from FDA-approved drug records, orphan drug designations, and FDA Adverse Event Reporting System (FAERS) safety data. GeneReviews management guidance is included where available.

No approved treatments are currently available for Waardenburg syndrome. The disease remains an area of unmet medical need.

GeneReviews

Management Guidelines

Evaluations Following Initial Diagnosis

To establish the extent of disease and needs in an individual diagnosed with Waardenburg syndrome type I (WS1), the following evaluations (if not performed as part of the evaluation that led to the diagnosis) are recommended:

Audiology evaluation

Prognosis

Based on GeneReviews surveillance recommendations, HPO phenotype frequency and severity annotations, and published prevalence estimates from Orphanet and OMIM.

GeneReviews

Surveillance Guidelines

The hearing loss in WS1 is typically non-progressive. Hence, repeat audiogram would usually not be necessary.

Source: GeneReviews — "Waardenburg Syndrome Type I"

Estimated prevalence: 1-9 in 100,000 (Uncommon).

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.

91 publications have been identified in PubMed for Waardenburg syndrome. Research spans Case Report / Case Series (32%), Basic Science / Preclinical (29%), and Review / Meta-Analysis (14%).

Research Type	Count	% of Total
Patient case studies	29	32%

Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 3:09 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:3440

GARD

Genetic and Rare Diseases Info Center

GARD:5525

Questions for Your Care Team

→Are any of the 1 active clinical trial a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

FAQ

Frequently Asked Questions

Common questions about Waardenburg syndrome

Waardenburg syndrome is a condition that affects the hearing and the pigmentation of the eyes, hair, and skin. It is caused by variations in the development of neural crest cells, which play a key role in forming these structures. There are four clinical and genetic types of Waardenburg syndrome, and each type can show a range of features. Many people with this condition experience some degree of hearing loss along with pigment differences, making each case unique.

Common features of Waardenburg syndrome include varying degrees of hearing loss and changes in pigmentation of the eyes, hair, and skin. Minor defects in structures that arise from neural crest cells may also be seen, but the presentation can differ from one person to another.

Waardenburg syndrome is linked to genetic changes that affect the development of neural crest cells. The syndrome is classified into four different genetic types. However, detailed information about the specific genetic causes is currently limited for this condition. Associated genes include PAX3, KITLG.

← Back to All Diseases

GeneReviews

Differential Diagnosis

Waardenburg syndrome type I (WS1) needs to be differentiated from other causes of congenital, non-progressive sensorineural hearing loss (see Hereditary Hearing Loss and Deafness Overview) and from other forms of Waardenburg syndrome. Waardenburg syndrome type II (WS2). WS1 is distinguished from WS2 by the presence in WS1 of lateral displacement of the inner canthi (dystopia canthorum). If the average W index across a family is less than 1.95, the diagnosis is WS2. Sensorineural hearing loss and heterochromia iridum are the two most characteristic features of WS2. Both are more common in WS2 than WS1. White forelock and leukoderma are both more common in WS1 than in WS2 . Table 4. Comparison of Clinical Features in Waardenburg Syndrome Type I and Waardenburg Syndrome Type II Clinical Finding | % of Affected Persons WS1 | WS2

Sensorineural hearing loss	47%-58%	77%-80%
Heterochromic irides	15%-31%	42%-54%
Hypoplastic blue irides	15%-18%	3%-23%
White forelock	43%-48%	16%-23%
Early graying	23%-38%	14%-30%
Leukoderma	22%-36%	5%-12%
High nasal root	52%-100%	0%-14%
Medial eyebrow flare	63%-73%	7%-12% Based on , , WS1 = Waardenburg syndrome type I; WS2 = Waardenburg syndrome type II Table 5.
Genes of Interest in the Differential Diagnosis of Waardenburg Syndrome Type I Gene(s)	Disorder	MOI
SOX10	WS2 (OMIM PS193500)	ADAR
SOX10	WS4 (OMIM PS193500)	ADAR
SNAI2	Piebaldism (OMIM 172800)	AD
MITF	Tietz syndrome (OMIM 103500)	AD

Source: GeneReviews — "Waardenburg Syndrome Type I"

Kisho

Waardenburg syndrome

Overview

Clinical Presentation

Clinical Guidance

Diagnosis

Diagnostic Criteria

Suggestive Findings

Treatment

Management Guidelines

Evaluations Following Initial Diagnosis

Prognosis

Surveillance Guidelines

Research Landscape

Medical References

External Resources

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Differential Diagnosis

Treatment of Manifestations

Surveillance

Evaluation of Relatives at Risk

Pregnancy Management

Therapies Under Investigation

Clinical Trials

Recent Publications

Waardenburg syndrome

Overview

Clinical Presentation

Clinical Guidance

Diagnosis

Diagnostic Criteria

Suggestive Findings

Treatment

Management Guidelines

Evaluations Following Initial Diagnosis

Prognosis

Surveillance Guidelines

Research Landscape

Medical References

External Resources

Orphanet

GARD

Subtypes

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is Waardenburg syndrome?

What are the symptoms of Waardenburg syndrome?

What causes Waardenburg syndrome?

How rare is Waardenburg syndrome?

How is Waardenburg syndrome diagnosed?

Are there treatments for Waardenburg syndrome?

What are the potential complications of Waardenburg syndrome?

How does Waardenburg syndrome affect daily life?

What is the prognosis for someone with Waardenburg syndrome?

Can Waardenburg syndrome affect family planning?

Differential Diagnosis

Treatment of Manifestations

Surveillance

Evaluation of Relatives at Risk

Pregnancy Management

Therapies Under Investigation

Clinical Trials

Recent Publications